AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUN 4 - (NewsRx.com & NewsRx.net) -- The WHO Viral Hepatitis Prevention Board recently presented their findings on hepatitis B vaccines.
According to recent research published in the journal Vaccine, "The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. The currently available and/or licensed combined hepatitis B vaccines in Europe and the prospects for further such vaccines were reviewed."
"Data on the safety, immunogenicity, and European licensing status and availability of haxavalent vaccines combining hepatitis B (HepB), Haemophilus influenza type b (Hib), diphtheria, tetanus, and pertussis (acellular) (DTPa), and inactivated poliovirus (IPV) antigens were presented," said David FitzSimons and fellow members of the Viral Hepatitis Prevention Board (VHPB) of the World Health Organization.
"Finally, the impact of the availability of combined ...
Source: HighBeam Research, Viral Hepatitis Prevention Board presents findings on hepatitis B...